EKSO BIONICS HOLDINGS, INC. - Common Stock, $0.001 par value per share (EKSO)

Q: What does CUSIP 282644400 represent in this 13F holders report?

CUSIP 282644400 is the security identifier for EKSO - EKSO BIONICS HOLDINGS, INC. - Common Stock, $0.001 par value per share used to aggregate holder disclosures.

Q: How many institutions held EKSO - EKSO BIONICS HOLDINGS, INC. - Common Stock, $0.001 par value per share in Q2 2025?

29 institutional investors reported EKSO - EKSO BIONICS HOLDINGS, INC. - Common Stock, $0.001 par value per share for Q2 2025. Use the holders table for investor-level position and value details.

CUSIP: 282644400

Q2 2025 13F Holders as of 30 Jun 2025

Type / Class: Equity / Common Stock, $0.001 par value per share
Shares outstanding: 2,914,374
Total 13F shares: 56,853
Share change: +56,853
Total reported value: $186,595
Price per share: $3.29
Number of holders: 29
Value change: +$186,595
Number of buys: 29

Quarterly Holders Quick Answers

What is CUSIP 282644400?
CUSIP 282644400 identifies EKSO - EKSO BIONICS HOLDINGS, INC. - Common Stock, $0.001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2025

Recent filing periods for CUSIP 282644400:

Q1 2026 Q4 2025 Q3 2025 Q2 2025

Top shareholders of EKSO - EKSO BIONICS HOLDINGS, INC. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
GILEAD SCIENCES, INC.	13F	Company	14%	2,209,471	$21,122,543	—	31 Mar 2025	13F
ARMISTICE CAPITAL, LLC	13D/G 13F	Company	10%	289,876	$5,252,553	$0	30 Jun 2025	13D/G 13F
VANGUARD GROUP INC	13F	Company	— mixed-class rows	809,631 mixed-class rows	$2,304,037	—	31 Mar 2025	13F
B Group, Inc.	13F	Company	1.3%	200,000	$1,912,000	—	31 Mar 2025	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	— mixed-class rows	195,427 mixed-class rows	$1,116,346	—	31 Mar 2025	13F
BlackRock, Inc.	13F	Company	— mixed-class rows	133,737 mixed-class rows	$777,189	—	31 Mar 2025	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	— mixed-class rows	246,723 mixed-class rows	$536,401	—	31 Mar 2025	13F
Steven Sherman	3/4/5	Executive Chair	— class O/S missing	449,153	$447,177	—	08 Jun 2023	3/4/5
Kent Lake PR LLC	13D/G	—	4.6%	1,000,000	$403,000	$0	31 Dec 2024	13D/G
MONIMUS CAPITAL MANAGEMENT, LP	13F	Company	0.27%	42,067	$402,161	—	31 Mar 2025	13F
NORTHERN TRUST CORP	13F	Company	— mixed-class rows	53,173 mixed-class rows	$280,783	—	31 Mar 2025	13F
FEDERATED HERMES, INC.	13F	Company	0.16%	25,394	$242,767	—	31 Mar 2025	13F
ACADIAN ASSET MANAGEMENT LLC	13F	Company	0.15%	23,027	$219,000	—	31 Mar 2025	13F
STATE STREET CORP	13F	Company	— mixed-class rows	152,589 mixed-class rows	$189,774	—	31 Mar 2025	13F
CITADEL ADVISORS LLC	13F	Company	— mixed-class rows	191,205 mixed-class rows	$189,302	—	31 Mar 2025	13F
Corinna Lathan	3/4/5	Director	13%	462,409	$186,350	—	16 May 2025	3/4/5
Kecheng Li	3/4/5	Director	13%	460,940	$185,758	—	16 May 2025	3/4/5
Mary Ann Cloyd	3/4/5	Director	13%	456,707	$184,052	—	16 May 2025	3/4/5
Squarepoint Ops LLC	13F	Company	0.12%	18,982	$181,468	—	31 Mar 2025	13F
MARSHALL WACE, LLP	13F	Company	0.11%	18,040	$172,462	—	31 Mar 2025	13F
Palumbo Wealth Management LLC	13F	Company	0.11%	17,986	$171,947	—	31 Mar 2025	13F
Man Group plc	13F	Company	0.11%	17,952	$171,621	—	31 Mar 2025	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.11%	17,414	$166,478	—	31 Mar 2025	13F
Stanley Stern	3/4/5	Director	— class O/S missing	167,008	$166,273	—	04 Dec 2022	3/4/5
BRIDGEWAY CAPITAL MANAGEMENT, LLC	13F	Company	0.1%	15,225	$145,551	—	31 Mar 2025	13F
Jack Peurach	3/4/5	President & CEO, Director	— class O/S missing	146,142	$145,499	—	31 Aug 2021	3/4/5
Rhonda A. Wallen	3/4/5	Director	— class O/S missing	142,288	$141,662	—	08 Jun 2023	3/4/5
Deborah Lafer Scher	3/4/5	Director	8.9%	314,419	$126,710	—	16 May 2025	3/4/5
AMERICAN CENTURY COMPANIES INC	13F	Company	0.07%	11,799	$112,798	—	31 Mar 2025	13F
Cresset Asset Management, LLC	13F	Company	7.6%	269,474	$108,598	—	31 Mar 2025	13F
Connor, Clark & Lunn Investment Management Ltd.	13F	Company	0.06%	10,182	$97,340	—	31 Mar 2025	13F
William R. Shaw	3/4/5	Chief Commercial Officer	— class O/S missing	96,943	$96,516	—	17 Feb 2022	3/4/5
FMR LLC	13F	Company	0.04%	5,659	$54,100	—	31 Mar 2025	13F
John Glenn	3/4/5	Chief Financial Officer	— class O/S missing	35,130	$34,975	—	22 Mar 2022	3/4/5
BARCLAYS PLC	13F	Company	0.02%	3,431	$32,800	—	31 Mar 2025	13F
MORGAN STANLEY	13F	Company	— mixed-class rows	2,362 mixed-class rows	$22,013	—	31 Mar 2025	13F
FNY Investment Advisers, LLC	13F	Company	1.5%	52,500	$21,000	—	31 Mar 2025	13F
Lombard Odier SCmA Compagnie	13F	Individual	0.71%	25,000	$10,075	—	31 Mar 2025	13F
Virtu Financial LLC	13F	Company	0.68%	23,905	$10,000	—	31 Mar 2025	13F
UBS Group AG	13F	Company	— mixed-class rows	2,206 mixed-class rows	$7,913	—	31 Mar 2025	13F
Golden State Wealth Management, LLC	13F	Company	0.55%	19,505	$7,861	—	31 Mar 2025	13F
TWO SIGMA SECURITIES, LLC	13F	Company	0.48%	16,853	$6,792	—	31 Mar 2025	13F
IFP Advisors, Inc	13F	Company	0.42%	15,000	$6,045	—	31 Mar 2025	13F
Tower Research Capital LLC (TRC)	13F	Company	— mixed-class rows	6,776 mixed-class rows	$6,036	—	31 Mar 2025	13F
HRT FINANCIAL LP	13F	Company	0.48%	17,082	$6,000	—	31 Mar 2025	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.31%	10,817	$4,359	—	31 Mar 2025	13F
RESOURCES MANAGEMENT CORP /CT/ /ADV	13F	Company	0.28%	10,000	$4,000	—	31 Mar 2025	13F
BNP PARIBAS FINANCIAL MARKETS	13F	Company	0%	302	$2,887	—	31 Mar 2025	13F
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO	13F	Company	0%	260	$2,486	—	31 Mar 2025	13F
RHUMBLINE ADVISERS	13F	Company	0%	190	$1,816	—	31 Mar 2025	13F

Institutional Holders of EKSO BIONICS HOLDINGS, INC. - Common Stock, $0.001 par value per share (EKSO) as of Q2 2025

As of 30 Jun 2025, EKSO BIONICS HOLDINGS, INC. - Common Stock, $0.001 par value per share (EKSO) was held by 29 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 56,853 shares. The largest 10 holders included Cresset Asset Management, LLC, GEODE CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC, BlackRock, Inc., FNY Investment Advisers, LLC, Compagnie Lombard Odier SCmA, Tower Research Capital LLC (TRC), Golden State Wealth Management, LLC, Roble, Belko & Company, Inc, and IFP Advisors, Inc. This page lists 29 institutional shareholders reporting positions in this security for the Q2 2025 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2025 vs Q4 2025 Across Filers

Q4 2025 holders

Q2 2025 holders

Holder diff

Investor	Q4 2025 Shares	Q2 2025 Shares	Share Diff	Share Chg %	Q4 2025 Value $	Q2 2025 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.